Maddalena Gaeta

Maddalena Gaeta

Auto-generated profile, based on publicly available information

Maddalena Gaeta

Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Journal of Urology
Verified
Journal Article
Closed access
SPStefano Picozzi
Stefano Picozzi
Cristian RicciCristian Ricci
Cristian Ricci
MGMaddalena Gaeta
Maddalena Gaeta
DRDario Ratti
Dario Ratti
AMAlberto Macchi
Alberto Macchi
LCLuca Carmignani
Luca Carmignani
Patients who undergo radical cystectomy for urothelial cancer are at risk for upper urinary tract disease in the remnant transitional tissue. Previous studies have identified several risk factors for upper urinary tract recurrence but the predictive value of each factor remains controversial. Furthermore, the schedule for surveillance of the upper urinary tract with imaging techniques and cytology has not been established. International guidelines do not address these topics and refer only to isolated works with a large case based analysis. We performed this meta-analysis to evaluate the effective incidence of upper urinary tract recurrence after cystectomy for bladder cancer, to analyze the risk factors so we can create subgroups of patients at high risk for recurrence and to investigate the real role of screening in the detection of upper tract lesions at an early stage. A bibliographic search covering the period from January 1970 to July 2010 was conducted using PubMed®, MEDLINE and EMBASE®. This analysis is based on the 27 studies that fulfilled the predefined inclusion criteria. Data were analyzed using a fixed effect logistic regression approach and classic meta-analysis. A total of 13,185 participants were included in the analysis. Followup was described in 22 studies and ranged from 0.36 to 349.2 months. The overall prevalence of upper tract transitional cell cancer after cystectomy ranged from 0.75% to 6.4%. Recurrence appeared at a range of 2.4 to 164 months, and in an advanced (64.6%) or metastatic state (35.6%) as reflected in poor survival rates. Patients with low grade vs high grade lesions at cystectomy showed as strong a significant difference in incidence as those with carcinoma in situ and superficial cancer vs invasive cancers and as strong as in those without lymph node involvement, with multifocal disease, with a history of multiple urothelial recurrences, with positive ureteral margins, with positive urethral margins, with urethral involvement and a history of upper urinary tract urothelial cancer. Data do not support a statistically significant difference in recurrence among patients with a history of carcinoma in situ, solitary lesion and among various types of urinary diversion adopted. In 24 studies the followup schedule included periodic radiological assessment of the upper urinary tract and in 20 it included urinary cytology. In 14 studies in 63 of 166 patients (38%) upper urinary tract recurrence was diagnosed by followup investigation whereas in the remaining 62% diagnosis was based on symptoms. When urine cytology was used in surveillance the rate of primary detection was 7% and with upper urinary tract imaging it was 29.6%. Of 5,537 patients who underwent routine cytological examination, recurrence was diagnosed in 1.8/1,000 and of those who underwent upper urinary tract imaging recurrence was diagnosed in 7.6/1,000. The recurrence values could appear low when considering the pan-urothelial field defect theory, but these values reflect, in part, the mortality associated with the initial bladder cancer. Based on anamnesis and pathological examination of cystectomy specimens, a group of patients is at high risk. Extensive regular followup with cytology, urography and loopgraphy yields insufficient benefits. Periodic computerized tomography with urography combines the ability to study the upper urinary tract oncologically and functionally, and the identification of any parenchymal, osseous or lymph node secondary lesion.

1 October 2012 in JACC
Verified
Journal Article
Closed access
RCRiccardo Cappato
Riccardo Cappato
SCserenella castelvecchio
serenella castelvecchio
Cristian RicciCristian Ricci
Cristian Ricci
EBElisabetta Bianco
Elisabetta Bianco
LVLaura Vitali-Serdoz
Laura Vitali-Serdoz
PLPier Paolo Lupo
Pier Paolo Lupo

21 September 2014 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
Cristian RicciCristian Ricci
Cristian Ricci
MGMaddalena Gaeta
Maddalena Gaeta
EREmanuele Rausa
Emanuele Rausa
EAEmanuele Asti
Emanuele Asti
FBFrancesco Bandera
Francesco Bandera
Luigi BonavinaLuigi Bonavina
Luigi Bonavina

10 November 2013 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
Cristian RicciCristian Ricci
Cristian Ricci
MGMaddalena Gaeta
Maddalena Gaeta
EREmanuele Rausa
Emanuele Rausa
YMYuri Macchitella
Yuri Macchitella
Luigi BonavinaLuigi Bonavina
Luigi Bonavina

1 August 2016 in JACC: Heart Failure
Verified
Journal Article
Closed access
MGMarco Guazzi
Marco Guazzi
Simona VillaniSimona Villani
Simona Villani
GGGreta Generati
Greta Generati
Ottavia Eleonora FerraroOttavia Eleonora Ferraro
Ottavia Eleonora Ferraro
MPMarta Pellegrino
Marta Pellegrino
FBFrancesco Bandera
Francesco Bandera

Vincenzo RestivoVincenzo Restivo
Vincenzo Restivo
Giuseppa MinutoloGiuseppa Minutolo
Giuseppa Minutolo
ABAlberto Battaglini
Alberto Battaglini
ACAlberto Carli
Alberto Carli
MCMichele Capraro
Michele Capraro
Alessandra CasuccioAlessandra Casuccio
Alessandra Casuccio
To work efficiently in healthcare organizations and optimize resources, team members should agree with their leader’s decisions critically. However, nowadays, little evidence is available in the literature. This systematic review and meta-analysis has assessed the effectiveness of leadership interventions in improving healthcare outcomes such as performance and guidelines adherence. Overall, the search strategies retrieved 3,155 records, and 21 of them were included in the meta-analysis. Two databases were used for manuscript research: PubMed and Scopus. On 16th December 2019 the researchers searched for articles published in the English language from 2015 to 2019. Considering the study designs, the pooled leadership effectiveness was 14.0% (95%CI 10.0–18.0%) in before–after studies, whereas the correlation coefficient between leadership interventions and healthcare outcomes was 0.22 (95%CI 0.15–0.28) in the cross-sectional studies. The multi-regression analysis in the cross-sectional studies showed a higher leadership effectiveness in South America (β = 0.56; 95%CI 0.13, 0.99), in private hospitals (β = 0.60; 95%CI 0.14, 1.06), and in medical specialty (β = 0.28; 95%CI 0.02, 0.54). These results encourage the improvement of leadership culture to increase performance and guideline adherence in healthcare settings. To reach this purpose, it would be useful to introduce a leadership curriculum following undergraduate medical courses.